Fetal Fibronectin
Test Summary
Fetal fibronectin can be detected in cervicovaginal secretions of women throughout pregnancy by use of this monoclonal antibody-based immunoassay. Fetal fibronectin is elevated in cervicovaginal secretions during the first 24 weeks of pregnancy but is diminished between 24 and 34 weeks in normal pregnancies. The significance of its presence in the vagina during the first 24 weeks of pregnancy is not understood. However, it may simply reflect the normal growth of the extravilous trophoblast population and the placenta. Detection of fFN in cervicovaginal secretions between 24 and 34 completed weeks gestation is reported to be associated with preterm delivery in symptomatic and asymptomatic pregnant women.
Aliases
N/A
Specimen Collection
Special Instructions
Preferred Specimen
Minimum Volume
Instructions
Patient Preparation
Storage
Transport Temperature
Specimen Stability
- Room Temperature = n/a
- Refrigerated = 3 days on ice slurry
- Frozen = n/a
Limitations
Other Acceptable Specimens
Unacceptable Specimens
Order Code
EPIC (Premier) Code
Includes
CPT Code
- 82731
Billing Code
- 300236
CPT Statement
Methodology
FDA Status
Physician Attestation of Informed Consent
Testing Laboratory
2308 Sandridge Drive
Moraine OH, 45439
Department
Reference Range
Setup Schedule / Expected Turnaround Time
Specimen Collection
Special Instructions
Preferred Specimen
Minimum Volume
Instructions
Patient Preparation
Storage
Transport Temperature
Specimen Stability
- Room Temperature = n/a
- Refrigerated = 3 days on ice slurry
- Frozen = n/a